Breast cancer patient-reported outcomes on level 1 and level 2 oncoplastic procedures using BREAST-Q®
C. A. Pinto, B. Peleteiro, C. S. Pinto, F. Osório, S. Costa, A. Magalhães, H. Mora, J. Amaral, D. Gonçalves & . J.L.Fougo
Abstract
Purpose
In breast cancer management not only mortality and surgical morbidity measurements are important but also patient satisfaction indexes. The authors evaluated the satisfaction and health-related quality of life (HRQOL) using the breast-conserving therapy (BCT) and breast reduction (BR) modules of BREAST-Q®.
Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients
Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients
C. S. Pinto; B. Peleteiro; · C. A. Pinto; F. Osório; S. Costa; A. Magalhães; H. Mora; · J. Amaral; D. Gonçalves; J. L. Fougo
Abstract
Background Targeted axillary dissection (TAD) combines sentinel node biopsy (SNB) with the removal of the previously marked metastatic node. TAD is a promising concept for axillary restaging in node-positive breast cancer patients with pathological complete response (pCR) to neoadjuvant therapy (NAT). We aimed to evaluate TAD feasibility in this context.
Health-Related Quality of Life After Nipple-Sparing Mastectomy: Results From the INSPIRE Registry
Health-Related Quality of Life After Nipple-Sparing Mastectomy: Results From the INSPIRE Registry
Antonio J. Esgueva, MD, PhD, Iris Noordhoek, Elma Meershoek-Klein Kranenbarg, Martin Espinosa-Bravo, Zolta ́n Ma ́trai, Andrii Zhygulin, Arvids Irmejs, Carlos Mavioso, Francesco Meani, Eduardo Gonzalez, Murat O ̈ zdemir, Tanir Allweis, Karol Rogowski, Catarina Rodrigues dos Santos, Henrique Mora, Riccardo Ponzone, Domenico Samorani, Cornelis van de Velde, Riccardo A. Audisio, Isabel T. Rubio, MD, PhD on behalf of the INSPIRE collaborators group
Abstract
Introduction. Nipple-sparing mastectomy (NSM) with immediate breast reconstruction (IBR) is increasingly used for both breast cancer (TNSM) and risk reduction (RRNSM). The aim of the study is to report the results of the INSPIRE registry assessing health-related quality of life (HRQoL) comparing baseline and 1-year follow-up, regarding surgical indications and chemotherapy (CT) received.